Understanding RPN1's Role in Cancer and Immune Response
Author Information
Author(s): Qin Lexin, Liang Tingting, Zhang Hailong, Gong Xian, Wei Meidan, Song Xiangrong, Hu Yaoyu, Zhu Xinyu, Hu Wentao, Li Jianxiang, Wang Jin
Primary Institution: School of Public Health, Suzhou Medicine College of Soochow University, Jiangsu, Suzhou, China
Hypothesis
This study aims to dissect the role of RPN1 in pan-cancer and its potential as a therapeutic target.
Conclusion
RPN1 is overexpressed in various tumors and is associated with poor clinical outcomes, suggesting it could be a target for cancer therapy.
Supporting Evidence
- RPN1 is overexpressed in a wide range of tumor types.
- High RPN1 expression correlates with poor overall survival and disease-specific survival.
- Knockdown of RPN1 reduces tumor cell proliferation and induces cellular senescence.
Takeaway
RPN1 is a protein that helps cancer cells grow and avoid the immune system, and blocking it might help treat cancer better.
Methodology
The study used pan-cancer analysis to explore RPN1 expression and its association with clinical outcomes across multiple tumor types, including immune cell infiltration and cellular senescence markers.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website